ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹15,712 Cr | ₹9,042 Cr | ₹5,340 Cr | ₹5,527 Cr | ₹7,827 Cr |
What is the latest Total Current Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹15,712 Cr |
| Mar2025 | ₹9,042 Cr |
| Mar2024 | ₹5,340 Cr |
| Mar2023 | ₹5,527 Cr |
| Mar2022 | ₹7,827 Cr |
How is Total Current Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹15,712 Cr | 73.77 | |
| Mar2025 | ₹9,042 Cr | 69.33 | |
| Mar2024 | ₹5,340 Cr | -3.38 | |
| Mar2023 | ₹5,527 Cr | -29.39 | |
| Mar2022 | ₹7,827 Cr | - | |
Compare Total Current Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹114,762.4 Cr | 0.2% | 4.8% | 16.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | 0.2% |
4.8% |
16.1% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses